• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Etripamil Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754847

Etripamil is an antagonist of short-acting L-type calcium-channel for the treatment,of Paroxysmal Supraventricular Tachycardia. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Etripamil, Inhibitor
Full Product Name
Etripamil
Product Synonym Names
MSP-2017; (-)-MSP-2017
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
452.59
Solubility
<1mg/ml refers to the product slightly soluble or insoluble
Formula
C27H36N2O4
SMILES
O=C(OC)C1=CC=CC(CCN(CCC[C@](C2=CC=C(OC)C(OC)=C2)(C#N)C(C)C)C)=C1
CAS Number
1593673-23-4
Target & IC50
L-type calcium channel
In Vitro
Etripamil displays atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells.

Structure of Etripamil, inhibitor

Etripamil Inhibitor – Cat# MBS5754847

Product References and Citations for Etripamil, inhibitor

Stambler BS, et al. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. J Am Coll Cardiol. 2018 Jul 31;72(5):489-497.
Stambler BS, et al. Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. J Am Coll Cardiol. 2018 Jul 31;72(5):489-497.
Milestone Pharmaceuticals Announces USAN Approval of Generic Name "Etripamil" for its Phase 2 Clinical Development Product for the treatment,of Paroxysmal Supraventricular Tachycardia.
Milestone Pharmaceuticals Announces USAN Approval of Generic Name "Etripamil" for its Phase 2 Clinical Development Product for the treatment,of Paroxysmal Supraventricular Tachycardia.

Other Notes

Small volumes of Etripamil, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Etripamil purchase

MBS5754847 is an inhibitor targeting Etripamil.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000